title: Use of partial liquid ventilation to manage pulmonary complications of acute verapamil-sustained release poisoning.
abstract: BACKGROUND
  Verapamil is a papaverine-derived calcium channel blocker widely used for the treatment of hypertension and supraventricular tachyarrhythmias. It is one of the leading agents involved in pharmaceutical poisoning-related deaths among adults.
  
  
  METHODS
  We report a case of severe sustained-release verapamil poisoning associated with respiratory failure in an adult man who survived after receiving 4 days of partial liquid ventilation as a part of his medical management.
authors.affiliation: Massachusetts General Hospital, Boston, USA.
authors.forename: L A
authors.initials: LA
authors.lastname: Szekely
authors.forename: B T
authors.initials: BT
authors.lastname: Thompson
authors.forename: A
authors.initials: A
authors.lastname: Woolf
mesh_terms: D000328:Adult; D000403:Airway Resistance / Q000187:drug effects; D002121:Calcium Channel Blockers / Q000506:poisoning*; D003692:Delayed-Action Preparations / Q000009:adverse effects*; D006801:Humans; D066298:In Vitro Techniques; D008297:Male; D010100:Oxygen / Q000097:blood; D011859:Radiography; D012128:Respiratory Distress Syndrome / Q000139:chemically induced; D012131:Respiratory Insufficiency / Q000139:chemically induced* / Q000628:therapy; D013406:Suicide, Attempted; D014691:Ventilation / Q000379:methods*; D014700:Verapamil / Q000506:poisoning*
chemical_list: D002121:Calcium Channel Blockers; D003692:Delayed-Action Preparations; D014700:Verapamil; D010100:Oxygen